Skip to main content
SpringerLink
Log in

Systemic glucocorticoids in chronic arthritis

  • Chapter
Glucocorticoids

Part of the book series: Milestones in Drug Therapy MDT ((MDT))

  • 385 Accesses

Abstract

Glucocorticoids offer a mode of treatment for arthritis that has been both seductive and controversial. The history of their use is linked with some of the most important advances in medical science this century. Philip Hench and his colleagues (who were awarded the Nobel Prize for discovering the anti-inflammatory properties of glucocorticoids) used them in rheumatoid arthritis (RA) with dramatic results [1]. The subsequent widespread use of glucocorticoids as anti-inflammatory agents made its mark in many conditions, with an inflammatory or auto-immune basis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) Effects of a hormone of the adrenal cortex (17-hydroxy-ll dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report. Proceedings Staff Meetings Mayo Clinic 24: 181–197

    CAS  Google Scholar 

  2. Kirwan JR, Silman AJ (1987) Epidemiological, social and environmental aspects of rheumatoid arthritis and osteoarthritis. Bailliere Clin Rheumatol 1: 467–489

    Article  CAS  Google Scholar 

  3. Kirwan JR, South West Regional Advisory Committee for Rheumatology (1994) The effect of National Health Service reforms on outpatient rheumatology workload. Brit J Rheumatol 33: 1181–1183

    Article  CAS  Google Scholar 

  4. Pincus T (1988) Rheumatoid arthritis: disappointing long-term outcomes despite successful short term-clinical trials. J Clin Epidemiol 41: 1037–1041

    Article  PubMed  CAS  Google Scholar 

  5. Scott DL, Spector TD, Pullar T, McConkey B (1989) What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis 48: 256–261

    Article  PubMed  CAS  Google Scholar 

  6. Weisman MH (1993) Should steroids be used in the management of rheumatoid arthritis? Rheum Dis Clin NAmer 19: 189–199

    CAS  Google Scholar 

  7. Harris EDJr, Emkey RD, Nicholas JE, Newberg A (1983) Low dose prednisolone therapy in rheumatoid arthritis. A double blind study. JRheum 10: 713–721

    Google Scholar 

  8. Weiss MM (1989) Corticosteroids in rheumatoid arthritis. Semin Arthr Rheum 19(1): 9–21

    Article  CAS  Google Scholar 

  9. Kirwan JR, Byron M, Dieppe P, Eastmond C, Halsey J, Hickling P, Hollingworth P, Jacoby R, Kirk A, Moran C et al (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. NEJM 333: 3: 142–146

    Article  PubMed  CAS  Google Scholar 

  10. Hickling P, Jacoby RK, Kirwan JR, The Arthritis, Rheumatism Council Low-Dose Glucocorticoid Study Group (1998) Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Brit J Rheumatol 37: 930–936

    Article  CAS  Google Scholar 

  11. Boers M, Verhoeven AC, Markusse HM, van de Laar M, Westhovens R, van Denderen J, van Zeben D, Dijkmans B, Peeters A, Jacobs P (1997) Randomised comparison of combined step down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309–318

    Article  PubMed  CAS  Google Scholar 

  12. Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S (1996) Low-dose corticosteroids in rheumatoid arthritis. A meta-analysisof their moderate-term effectiveness. Arthritis Rheumatism 39: 1818–1825

    Article  PubMed  CAS  Google Scholar 

  13. Panayi GS, Heberden Oration (1993) The pathogenesis of rheumatoid arthritis: From molecules to the whole patient. Brit J Rheumatol 32: 533–536

    Article  CAS  Google Scholar 

  14. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS (1992) Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheumatism 35: 1281–1288

    PubMed  CAS  Google Scholar 

  15. Joint Committee of the Medical Research Council, Nuffield Foundation (1954) A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. Brit Med J 29: 1223–1227

    Google Scholar 

  16. Empire Rheumatism Council (1955) Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Ann Rheum Dis 14: 353–367

    Article  Google Scholar 

  17. Joint Committee of the Medical Research Council, Nuffield Foundation (1959) A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 18: 173–187

    Article  Google Scholar 

  18. Joint Committee of the Medical Research Council, Nuffield Foundation (1960) A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 19: 331–337

    Article  Google Scholar 

  19. West HF (1967) Rheumatoid arthritis. The relevance of clinical knowledge to research activities. Abstracts World Medicine 41: 401–417

    Google Scholar 

  20. Masi AT (1983) Low dose glucocorticoid therapy in rheumatoid arthritis. J Rheumatol 10: 675–678

    PubMed  CAS  Google Scholar 

  21. Berntsen CA, Freyberg RH (1961) Rheumatoid patients after five or more years of glucocorticoid treatment: A comparative analysis of 183 cases. Ann Intern Med 54: 938–953

    Google Scholar 

  22. Leibling MR, Leib E, McLaughlin K (1981) Pulse methyl-prednisolone in rheumatoid arthritis. Ann Intern Med 4: 21–26

    Google Scholar 

  23. Harris EDJr, Emkey RD, Nichols JE, Newberg A (1983) Low dose prednisolone therapy in rheumatoid arthritis: A double blind study. J Rheumatol 10: 713–721

    PubMed  Google Scholar 

  24. Million R, Poole P, Kellgren JH, Joyson J (1984) Long-term study of management of rheumatoid arthritis. Lancet 1: 812–816

    Article  PubMed  CAS  Google Scholar 

  25. Hansen TM, Kryger P, Elling H, Haar D, Kreutzfeldt M, Ingeman-Nielsen MW, Olsson AT, Pedersen C, Rahbek A, Tvede N, Winge J (1990) Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. BMJ 301: 268–270

    Article  PubMed  CAS  Google Scholar 

  26. Byron MA, Kirwan JR (1986) Corticosteroids in rheumatoid arthritis: Is a trial of their’ disease modifying’ potential feasible? Ann Rheum Dis 46: 171–173

    Article  Google Scholar 

  27. Bresnihan B, Mulherin D, FitzGerald O (1995) Synovial pathology and articular erosions in rheumatoid arthritis. Rheumatology in Europe 24 (Suppl 2): 158–160

    Google Scholar 

  28. Kirwan JR (1997) The relationship between synovitis and erosions in rheumatoid arthritis. Brit J Rheumatol 36: 225–228

    Article  CAS  Google Scholar 

  29. Kirwan JR, Currey HLF (1983) Rheumatoid arthritis: disease modifying anti-rheumatoid drugs. Clin Rheum Dis 9: 581–599

    PubMed  CAS  Google Scholar 

  30. George E, Kirwan JR (1990) Glucocorticoid therapy in rheumatoid arthritis. Bailliere Clin Rheum 4: 621–647

    Article  CAS  Google Scholar 

  31. Brook A, Corbett M (1977) Radiographic change in early rheumatoid disease. Ann Rheumat Dis 36: 71–73

    Article  PubMed  CAS  Google Scholar 

  32. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiologica 18: 481–491

    CAS  Google Scholar 

  33. Caldwell JR, Furst DE (1991) The efficacy and safety of low-dose cortiosteroids for rheumatoid arthritis. Sem Arthr Rheum 21; 1: 1–11

    Article  CAS  Google Scholar 

  34. Sambrook PN, Eisman JA, Ygates MG Pocock NA, Ebgrl S, Champion GD (1986) Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheumat Dis 45: 950–953

    Article  PubMed  CAS  Google Scholar 

  35. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Doyle DV (1993) The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 36: 11: 1510–1516

    Article  PubMed  CAS  Google Scholar 

  36. Adachi JD, Cranney A, Goldsmith CH et al (1994) Intermittent cyclic therapy with etidronate in the prevention of glucocorticoid induced bone loss. J Rheumatol 21; 10: 1922–1926

    PubMed  CAS  Google Scholar 

  37. Cooper C, Kirwan JR (1990) The risk of local and systemic corticosteroid administration. Bailliere Clin Rheumatol 4: 305–332

    Article  CAS  Google Scholar 

  38. Weusten BLAM, Jacobs JWG, Bijlsma JWJ (1993) Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum 23: 183–192

    Article  CAS  Google Scholar 

  39. Radia M, Furst DE (1988) Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis. J Rheumatol 15: 242–256

    PubMed  CAS  Google Scholar 

  40. Shipley ME, Bacon PA, Berry H, Hazleman BL, Sturrock RD, Swinson DR, Williams IA (1988) Pulsed methylprednisolone in active early rheumatoid disease. A dose ranging study. Brit J Rheumatol 27: 211–214

    Article  CAS  Google Scholar 

  41. Needs CJ, Smith M, Boutagy J et al (1988) Comaprison of methylprednisolone (1 gram IV) with prednisolone (1 gram orally) in rheuamtoid arthritis: a pharmokinetic and clinical study. J Rheumatol 15: 224–228

    PubMed  CAS  Google Scholar 

  42. Choy EHS, Kingsley G, Corkhill MM, Panayi GS (1993) Intramuscular methylprednisolone is superior to pulse oral methylprednisolone during the induction phase of chrysotherapy. Brit J Rheumatol 32: 734–739

    Article  CAS  Google Scholar 

  43. Conn D, Tomkins RB, Nichols WL (1988) Glucocorticoids in the management of vasculitis-a double edged sword? J Rheumatol 15(5): 1181–1183

    PubMed  CAS  Google Scholar 

  44. Salvarini C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castri C, Ciaravallot IF, Portioli I (1987) Polymyalgia rheumatica and giant cell arteritis: a 5-year rpidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 5: 205–215

    Google Scholar 

  45. Delecoeuillerie G, Joly P, de Lara AC, Paolaggi JB (1988) Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 47: 733–739

    Article  PubMed  CAS  Google Scholar 

  46. Lundberg I, Hedfors E (1990) Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol 17: 1340–1345

    PubMed  CAS  Google Scholar 

  47. Kirwan JR (1990) Treatment of polymyalgia rheumatica. Brit J Rheumatol 29: 316

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol Royal Infirmary, University Division of Medicine, Bristol, BS2 8HW, UK

    John R. Kirwan

Authors
  1. John R. Kirwan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept of Biochemical Pharmacology William Harvey Research Institute Barts and the London School of Medicine and Dentistry Queen Mary, University of London, Charterhouse Square, London, EC1M 6BQ, UK

    Nicolas J. Goulding  & Rod J. Flower  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Basel AG

About this chapter

Cite this chapter

Kirwan, J.R. (2001). Systemic glucocorticoids in chronic arthritis. In: Goulding, N.J., Flower, R.J. (eds) Glucocorticoids. Milestones in Drug Therapy MDT. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8348-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8348-1_11

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9528-6

  • Online ISBN: 978-3-0348-8348-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation